Abstract
purpose. To characterize physiologic intereye differences (PIDs) in optic nerve head (ONH) architecture in six normal rhesus monkeys and compare them to intereye differences in three previously reported cynomolgus monkeys with early experimental glaucoma (EEG).
methods. Trephinated ONH and peripapillary sclera from both eyes of six normal monkeys were serial sectioned, 3-D reconstructed, 3-D delineated, and parameterized. For each normal animal and each parameter, PID was calculated (both overall and regionally) by converting all left eye data to the right eye configuration and subtracting the right eye value from that of the left eye. Physiologic intereye percent difference (PIPD) was calculated as the PID divided by the measurement mean of the two eyes. For each EEG monkey, intereye (EEG minus normal) differences and percent differences for each parameter overall and regionally were compared to the PID and PIPD maximums.
results. For all parameters the PID maximums were relatively small overall. Compared to overall PID maximums, overall intereye differences in EEG monkeys were greatest for laminar deformation and thickening, posterior scleral canal enlargement, cupping, and prelaminar neural tissue thickening. Compared with the regional PID maximums, the lamina cribrosa was posteriorly deformed centrally, inferiorly, inferonasally, and superiorly and was thickened centrally. The prelaminar neural tissues were thickened inferiorly, inferonasally, and superiorly.
conclusions. These data provide the first characterization of PID and PIPD maximums for ONH neural and connective tissue parameters in normal monkeys and serve to further clarify the location and character of early ONH change in experimental glaucoma. However, because of the species differences, the findings in EEG should be confirmed in EEG rhesus monkey eyes.
In the monkey model of unilateral experimental glaucoma (EG), chronic intraocular pressure (IOP) elevation is induced in one eye of an animal, and the contralateral eye is maintained as the normal control.
1 2 3 4 5 6 7 8 9 10 In our laboratory, animals are killed at clinically defined endpoints of early, moderate, or severe glaucomatous damage on the basis of longitudinal confocal scanning laser tomographic (CSLT) imaging of the study eye, and then in a subset of experiments perfusion fixed with both eyes set to 10 mm Hg by anterior chamber manometer.
11 12 13 In these experiments, postmortem histomorphometric
11 12 13 analyses are then performed in which the differences between the treated and control eyes are assumed to be due to the pathophysiology of glaucomatous damage.
We recently introduced our method for three dimensional (3-D) delineation of 13 optic nerve head (ONH) and peripapillary sclera landmarks and used it to quantify enlargement and elongation of the neural canal at the onset of CSLT-detected ONH surface change in three monkeys with early experimental glaucoma (EEG) that occurred after moderate levels of IOP elevation in one eye.
11 In a second report,
12 we described our method for continuously mapping position and thickness of the lamina cribrosa, scleral flange, and peripapillary sclera and used it to report significant posterior deformation and thickening of the lamina cribrosa accompanied by mild posterior deformation of the scleral flange and peripapillary sclera in the same EEG eyes. In a third report,
13 we introduced our concept of prelaminar and laminar cupping, and used four new postmortem 3-D histomorphometric parameters to report that clinical cupping in early glaucoma is primarily due to fixed permanent posterior deformation of the ONH connective tissues and occurs in the setting of prelaminar tissues that are thickened.
The purpose of the present study was to characterize the upper range of physiologic intereye differences (PIDs) and physiologic intereye percent differences (PIPDs) in ONH neural and connective tissue architecture in six normal monkeys and compare them with intereye differences in the three previously reported monkeys with EEG in one eye,
11 12 13 to clarify the most important optic nerve head changes in early experimental glaucoma. Once clarified by region and character and confirmed in a larger number of EEG eyes (manuscripts in preparation), these changes should become important imaging targets in patients with moderate levels of ocular hypertension.
Generation of the Aligned Serial Section Images for Each ONH and 3-D ONH Reconstruction
Qualitative Inspection of Quantitative 3-D Neural Canal Size and Shape Data by Monkey
Regional Neural Canal Landmark Offset and Depth Measurement Means and PID Maximum
Regional Lamina Cribrosa Position and Thickness Measurement Means and PID Maximums
Regional Peripapillary Scleral Position and Thickness Measurement Means and PID Maximums
Regional Prelaminar Tissue Thickness and Volume Measurement Means and PID Maximums
Comparison of Overall PID and PIPD Maximums to Overall Intereye Differences in the Three Previously Reported EEG Animals
Comparison of Regional PID and PIPD Maximums to Regional Intereye Differences in the Three Previously Reported EEG Animals
The purpose of the present study was to characterize PIDs in ONH neural and connective tissue architecture in six normal monkeys and compare them to intereye differences in three previously reported monkeys with early experimental glaucoma in one eye.
11 12 13 The principal findings of this report are as follows. First, for all parameters considered, the PID maximums in these six normal animals were relatively small. EEG compared with normal eye differences in all three previously reported EEG monkeys consistently and substantially exceeded these overall PID and PIPD maximums for parameters related to laminar deformation, posterior scleral canal enlargement, cupping, and prelaminar neural tissue thickening. Second, regional PID and PIPD maximums were greater than the overall PID and PIPD maximums for most parameters. Only parameters related to laminar deformation and thickening in the central region and laminar deformation and prelaminar neural tissue thickening in the inferior, inferonasal, and superior regions exceeded these maximums in all three EEG animals.
That our overall PID and PIPD maximum data focuses attention on the parameters related to laminar deformation, posterior scleral canal enlargement, cupping, and prelaminar neural tissue thickening in EEG is important for two reasons. First, it establishes that at least for these three EEG monkeys relative to the six bilaterally normal monkeys, the model and our methods were sensitive enough to detect similar forms of early damage in all three EEG eyes. Second, it suggests that these processes may not just be the most detectable in our model/method system, but rather that they may be the most consistent early processes in experimental glaucomatous damage to the monkey ONH that occurs at moderate levels of IOP elevation.
Our regional PID maximums create a more conservative benchmark for the detection of early glaucomatous damage and further clarify that in these three EEG animals the earliest changes were laminar deformation and thickening in the central region and laminar deformation and prelaminar neural tissue thickening in the inferior, inferonasal, and superior regions. Although the human and monkey optic nerve heads may fundamentally differ in their clinical behavior, we propose that these changes, (now clarified by region and character), suggest important new imaging targets for patients with moderate levels of ocular hypertension. A study assessing these findings in a larger group of EEG monkeys is nearing completion and will be the subject of a future report.
Apart from our principal findings, several additional points bear discussing. First, while we report both the PID and PIPD maximums for each overall and regional parameter, we emphasize the PID maximum without extensively discussing it as a percentage difference (PIPD). We believe that the PID value alone is most relevant to the monkey experimental glaucoma model for cross-sectional detection of change in one eye compared with its contralateral normal control. Whereas PID estimates show the variability inherent in our method, PID data are not variability data alone but rather are estimates of the biological difference between the two normal eyes of an animal. Because our method achieves 1.5-μm voxel resolution, its accuracy is adequate to detect that the intereye differences among bilaterally normal eyes are different from the intereye differences of monkeys with experimental glaucoma in one eye. As such, we propose that requiring that the intereye difference in a given parameter exceed the upper range of its PID is a valid benchmark for change detection in the early glaucomatous eye of an animal, whether it is 0.1% or 50% of the measurement value in the contralateral normal eye.
However, we have included PIPD data (and used it as a criteria for change that is likely to be important), because in so doing, the data we report may be more applicable to similar measurements made with a clinical instrument in which the exact scale of the measurement cannot be certain. In the case of laminar position as measured by clinical Spectral Domain Optical Coherence Tomography (SD-OCT) in both eyes of an animal, the PIPD maximum for overall or regional laminar position conservatively estimates the percentage difference (between the treated and contralateral normal eye of a study animal) required to exceed the highest percent difference that occurred among these six pairs of bilaterally normal eyes.
Although we report measurement means and their range for each parameter, we do not extensively discuss their significance, as these data will soon be supplemented by the report of measurement means, 95% CI, and upper and lower range for each parameter in 41 normal eyes of 41 monkeys, ranging from 2 to 31 years of age, all perfusion fixed at 10 mm Hg IOP. These data will form the most comprehensive characterization of normal monkey ONH neural and connective tissue architecture to date and provide the source dimensions for parameterized finite element models, which will characterize the most important determinants of IOP-related stress and strain at all levels of IOP.
16 17 18 19 20
Our report should be considered in the context of the following limitations. First, the true range of physiologic intereye variation would be best characterized in hundreds of pairs of normal eyes and include groups designed to assess the effects of species, age, and asymmetries in ocular dimensions and refractive errors. Although we did not preselect these animals, that we happened to study six rhesus monkeys in which the eyes of each animal were very similar does not mean that more marked intereye differences are not present in some or even most normal rhesus monkeys. We therefore view our report as preliminary and hope to gradually add to these data through additional postmortem 3-D histomorphometric reconstruction of dedicated bilaterally normal animals as well as clinical SD-OCT ONH reconstructions
21 of bilaterally normal monkeys before their inclusion in our longitudinal studies of experimental glaucoma.
Because of circumstances beyond our control, we were forced to establish PID and PIPD maximums in rhesus monkeys that may not directly apply to the three cynomolgus EEG monkeys in our previous reports.
11 12 13 Although there may be differences in measurement means between the species, we believe that important species differences in PID and PIPD maximum are unlikely. By gross comparison, the right eye measurement ranges of all parameters for the six rhesus monkeys
(Table 2)are very similar to the normal eye ranges of the three cynomolgus EEG monkeys
(Table 3) . However, without having studied a large population of animals, the species difference between our normal and EEG groups add to the preliminary nature of our findings.
The measurement means and PID values reported herein are not the actual physiologic dimensions of the living monkey before death, because of uncharacterized tissue shrinkage effects (from both fixation and embedding) associated with our 3-D histomorphometric technique. However, since both eyes of each animal were treated identically (i.e., at the same time and in the same dehydration solutions), comparisons between the two eyes of each monkey should still be valid. It is within this context that the PIPD maximum we report may have the greatest relevance to any future study in which a consistent but uncertain shrinkage or measurement artifact is present.
It is possible that lowering IOP to 10 mm Hg 30 minutes before perfusion fixation induced the prelaminar tissue thickening seen in all three EEG eyes. However, we think this is unlikely for the following reasons. First, IOP was lowered to 10 mm Hg slowly (over 1–2 minutes), and second, in those eyes in which it was measured, IOP was not that high on the day of death: 37 mm Hg in the EEG eye of monkey 2, 18 mm Hg in the EEG eye of monkey 3, and not measured in the EEG eye of monkey 1 (but the maximum IOP ever detected in that monkey was 26 mm Hg and IOP was 22 mm Hg 4 days before death). Although it is possible that the change from 37 to 10 mm Hg caused the prelaminar thickening in EEG monkey 2, we doubt that the IOP change in EEG monkeys 1 and 3 accounts for this finding. It should also be noted that when we discussed these same data in our previous publication
13 we erroneously reported which animal had no IOP data on the day of death (monkey 3 instead of monkey 1) and the highest IOP recorded (32 mm Hg instead of 37 mm Hg). However, our interpretation of these data remains unchanged from that report.
13 We predict that longitudinal SD-OCT imaging of prelaminar tissue volume and thickness (once clinically available), will confirm this finding in hypertensive human and monkey eyes.
Finally, previous studies have demonstrated that IOPs in ketamine-anesthetized normal monkeys (mean ± SD, 14.9 ± 2.1 mm Hg)
22 are similar to those in normal humans (mean ± SD, 15.5 ± 2.6 mm Hg).
23 However, our IOP measurements in these normal animals were made after administration of a combination of intramuscular ketamine and xylazine, and the IOP in our animals (range, 8–14 mm Hg) are overall slightly lower than the mean IOP in monkeys.
22 There are two possible reasons for the lower IOP measurements: (1) the effects of ketamine can be time dependent
24 25 26 ; thus, IOP may have become more variable and lower than actual pressures in both the normal and glaucomatous monkey eye in our experimental settings; and (2) xylazine may have an additional pressure-lowering effect, which has been reported to significantly reduce IOP in rabbits, cats, and monkeys.
27
In conclusion, we have rigorously characterized the range of PID and PIPD maximums in ONH neural and connective tissue architecture in six normal rhesus monkeys. The PID and PIPD maximums of this report serve to clarify our previous studies in early experimental glaucoma and will now be used as reference values for a series of articles on intereye differences in ONH architecture in bilaterally normal monkeys as well as those with early, moderate, and severe EG, perfusion fixed with each eye at either identical or different levels of IOP.
Presented in part at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2008.
Supported in part by National Eye Institute Grant R01EY011610 (CFB); a grant from the American Health Assistance Foundation, Rockville, Maryland (CFB); a grant from The Whitaker Foundation, Arlington, Virginia (CFB); a Career Development Award (CFB); The Legacy Good Samaritan Foundation, Portland, Oregon; and the Sears Trust for Biomedical Research, Mexico, and Missouri.
Submitted for publication June 20, 2008; revised August 17, 2008; accepted November 17, 2008.
Disclosure:
H. Yang, None;
J.C. Downs, None;
C.F. Burgoyne, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Claude F. Burgoyne, Optic Nerve Head Research Laboratory, Devers Eye Institute, 1225 NE 2nd Avenue, PO Box 3950, Portland OR 97208-3950;
[email protected].
No. | ID | Weight (kg) | Age (y) | Sex | Eye | IOP, † (mm Hg) | Number of serial Section Images | Histomorphometric Optic Disc Size | | | | | |
---|
| | | | | | | | Optic Disc Dimension (μm)* | | | | Optic Disc Area (mm2) | |
---|
| | | | | | | | Vertical, ‡ | Vertical PID, § (PIPD %), ∥ | Horizontal, ¶ | Horizontal PID (PIPD %) | Area, # | Area PID (PIPD %) |
---|
1 | 99R1753 | 3 | 4 | Male | Right | 11 | 342 | 1636 | 26 (1.6) | 1193 | 14 (1.2) | 1.532 | 0.007 (0.4) |
| | | | | Left | 11 | 434 | 1662 | | 1179 | | 1.539 | |
2 | 97R0793 | 5 | 6 | Male | Right | 14 | 491 | 1444 | 3 (0.2) | 1060 | 17 (1.7) | 1.201 | 0.023 (1.9) |
| | | | | Left | 14 | 456 | 1447 | | 1077 | | 1.224 | |
3 | 23540 | 5.3 | 9 | Female | Right | 13 | 524 | 1520 | 10 (0.7) | 1072 | 16 (1.4) | 1.280 | 0.027 (2.1) |
| | | | | Left | 10 | 665 | 1530 | | 1088 | | 1.307 | |
4 | 23533 | 3.68 | 8 | Female | Right | 8 | 607 | 1355 | 18 (1.3) | 984 | 25 (2.6) | 1.048 | 0.014 (1.3) |
| | | | | Left | 8 | 528 | 1373 | | 959 | | 1.034 | |
5 | 23510 | 4.86 | 10 | Female | Right | 12 | 561 | 1439 | 40 (2.8) | 1044 | 18 (1.7) | 1.180 | 0.012 (1.0) |
| | | | | Left | 11 | 558 | 1479 | | 1026 | | 1.192 | |
6 | 25341 | 5.4 | 2 | Male | Right | 13 | 484 | 1420 | 14 (1.0) | 1076 | 21 (1.9) | 1.199 | 0.036 (3.0) |
| | | | | Left | 12 | 478 | 1434 | | 1097 | | 1.235 | |
Table 2. Overall Measurements Means, PIDs, and PIPDs for all Parameters within Six Bilaterally Normal Rhesus Monkeys
Table 2. Overall Measurements Means, PIDs, and PIPDs for all Parameters within Six Bilaterally Normal Rhesus Monkeys
| Measurement Mean* | Measurement Range | PID Range, † | PIPD Range (%), ‡ |
Optic Disk Size | | | | |
Vertical length (μm) | 1469 | 1355–1636 | 3–40 | 0.2–2.8 |
Horizontal length (μm) | 1071 | 984–1193 | 14–25 | 1.2–2.6 |
Disk area (mm2) | 1.240 | 1.048–1.532 | 0.007–0.036 | 0.4–3.0 |
Neural Canal Architecture | | | | |
BMO offset (μm) | 623 | 573–694 | 1–9 | 0.1–1.5 |
ASCO offset (μm) | 716 | 652–778 | 5–16 | 0.7–2.1 |
ALI offset (μm) | 720 | 650–784 | 5–16 | 0.7–2.2 |
PLI offset (μm) | 808 | 753–848 | 2–18 | 0.3–2.1 |
PSCO offset (μm) | 840 | 789–893 | 1–22 | 0.1–2.7 |
ASAS offset (μm) | 936 | 892–992 | 2–18 | 0.2–2.1 |
ASCO depth (μm) | 31 | 19–49 | 1–15 | 2.8–100.9 |
ALI depth (μm) | 36 | 21–50 | 1–20 | 2.8–89.6 |
PLI depth (μm) | 121 | 90–181 | 4–20 | 3.3–16.8 |
PSCO depth (μm) | 143 | 93–196 | 4–27 | 3.1–17.1 |
ASAS depth (μm) | 162 | 97–234 | 1–25 | 0.5–19.4 |
ONH Connective Tissue | | | | |
Lamina cribrosa position (μm) | −84 | −103–−68 | 6–16 | 6.1–21.1 |
Peripapillary scleral position, § (μm) | −11 | −39–32 | 0–21 | 0–400 |
Lamina cribrosa thickness (μm) | 104 | 81–136 | 1–16 | 0.7–18 |
Peripapillary scleral thickness, § (μm) | 160 | 137–195 | 0–11 | 0–7.1 |
Sclera flange thickness (μm) | 66 | 54–101 | 3–5 | 4.6–8.8 |
Mid-peripapillary scleral position, ∥ (μm) | −16 | −38–14 | 2–18 | 5.4–180 |
Mid-peripapillary scleral thickness , ∥ (μm) | 147 | 121–179 | 1–14 | 0.8–9.2 |
ONH Prelaminar Neural Tissue and Cupping | | | | |
Prelaminar tissue thickness, § (μm) | 160 | 95–193 | 1–15 | 0.5–8.9 |
Post-BMO cup volume, # (mm3) | 0.0081 | 0.0030–0.0159 | 0.0018–0.0056 | 13.1–174.4 |
Post-BMO total prelaminar volume (mm3) | 0.1358 | 0.1084–0.1870 | 0.0052–0.0440 | 3.7–28.4 |
Prelaminar tissue volume, § (mm3) | 0.2255 | 0.1682–0.2543 | 0.0098–0.0334 | 3.8–18.1 |
Table 3. Normal Eye Range and Treatment Eye Differences for Three Previously Reported Cynomolgus EEG monkeys
11 12 13 Compared with the PID (PIPD) Maximum
Table 3. Normal Eye Range and Treatment Eye Differences for Three Previously Reported Cynomolgus EEG monkeys
11 12 13 Compared with the PID (PIPD) Maximum
| Normal Eye Range of EEG Monkeys | EEG Monkey 1 ΔEEG (ΔEEG/N%)* | EEG Monkey 2 ΔEEG (ΔEEG/N%) | EEG Monkey 3 ΔEEG (ΔEEG/N%) | PID (PIPD%) Maximum, † |
Optic Disk Size | | | | | |
Vertical length, ‡ (μm) | 1337–1459 | 108 (8.1) | 1 (0.1) | 3 (0.2) | 40 (2.8) |
Horizontal length, ‡ (μm) | 1017–1055 | 47 (4.6) | 2 (0.2) | 68 (6.5) | 25 (2.6) |
Disk area, ‡ (mm2) | 1.068–1.209 | 0.140 (13.1) | 0.001 (0.1) | 0.081 (6.7) | 0.036 (3) |
Neural Canal Architecture | | | | | |
BMO offset (μm) | 579–615 | 39, § (6.7) | 2 (0.3) | 21 (3.4) | 9 (1.5) |
ASCO offset (μm) | 648–724 | 71, § (9.8) | 11 (1.7) | 1 (0.1) | 16 (2.1) |
ALI offset (μm) | 649–736 | 70, § (9.6) | 11 (1.7) | 4 (0.5) | 16 (2.2) |
PLI offset (μm) | 721–904 | 99, § (11.0) | 39, § (5.4) | 54, § (6.5) | 18 (2.1) |
PSCO offset (μm) | 743–940 | 85, § (9.0) | 19, § (2.6) | 30, § (3.5) | 22 (2.7) |
ASAS offset (μm) | 831–1038 | 98, § (9.4) | 39, § (4.7) | 74, § (7.5) | 18 (2.1) |
ASCO depth (μm) | 22–53 | 7 (31.8) | 4 (13.8) | 2 (3.8) | 15 (100.9) |
ALI depth (μm) | 22–64 | 7 (31.8) | 18, § (47.4) | 14, § (21.9) | 20 (89.6) |
PLI depth (μm) | 86–166 | −5 (5.8) | 39, § (23.5) | 14, § (9.7) | 20 (16.8) |
PSCO depth (μm) | 104–181 | −9 (8.7) | 25, § (13.8) | 7 (4.6) | 27 (17.1) |
ASAS depth (μm) | 125–185 | −25, § (20.0) | 9 (4.9) | −36, § (24.7) | 25 (19.4) |
ONH Connective Tissue | | | | | |
Lamina cribrosa position (μm) | −111–−105 | −118, § (115.7) | −97, § (87.4) | −79, § (75.2) | 16 (21.1) |
Lamina cribrosa thickness (μm) | 83–128 | 61, § (59.2) | 23, § (18.0) | 26, § (31.3) | 16 (18.0) |
Sclera flange thickness (μm) | 60–76 | 7 (10.1) | 1 (1.3) | 8 (13.3) | 5 (8.8) |
Mid-peripapillary sclera position (μm) | −14–45 | 21, § (46.7) | 3 (21.4) | 35, § (94.6) | 18 (180) |
Mid-peripapillary sclera thickness (μm) | 113–136 | −4 (2.94) | −32, § (25.4) | 1 (0.9) | 14 (9.2) |
ONH Prelaminar Neural Tissue and Cupping | | | | | |
Prelaminar tissue thickness (μm) | 95–110 | 82, § (74.5) | 47, § (47) | 58, § (61.1) | 15 (8.9) |
Post-BMO cup volume, ‡ (mm3) | 0.010–0.054 | 0.127 (235.2) | 0.058 (446.2) | 0.090 (900) | 0.0056 (174.4) |
Post-BMO total prelaminar volume, ‡ (mm3) | 0.159–0.231 | 0.308 (133.3) | 0.122 (76.7) | 0.191 (119.4) | 0.0440 (28.4) |
Prelaminar tissue volume, ‡ (mm3) | 0.232–0.289 | 0.167 (62.3) | 0.025 (10.8) | 0.002 (0.692) | 0.0334 (18.1) |
Supplementary Figure S1 -
(JPG)
Neural canal landmark offset data points for both eyes of each animal overlaid in right eye configuration. Neural canal landmarks
points projected onto the BMO zero reference plane for OS and OD eyes (
solid lines: OS eye data;
dotted lines: OD eye data) in right eye configuration with coincident BMO centroids (
black dot). Overall the neural canal structures were very similar in all the six animals except for obvious differences in the ASAS
for monkey 1, 2 and 3. To view BMO points co-localized to clinical color photos of each eye, please see Supplementary Figure
S2 and Supplementary Figure S3.
Clinical co-localization of the 3D histomorphometric reconstruction to pre-sacrifice clinical color photos for Monkeys 1,
2 and 3 demonstrated close co-localization of the 3-D histomorphometrically delineated BMO points (in dark red) to the clinically visible optic disc margin in most eyes, when retinal and ONH vessel (in pink) co-localization were maximized.
Clinical co-localization of the 3D histomorphometric reconstruction to pre-sacrifice clinical color photos for Monkeys 4,
5 and 6 demonstrate findings similar to Supplementary Figure S2, above. ONH vessels are in pink or gray.
The authors thank Jonathon Grimm, Juan Reynaud, and Michael Roberts for assistance with software for volumetric and thickness quantification; Galen Williams for help with delineation; Wenxia Wang for help with animal testing; Hillary Thompson and Stuart Gardiner for statistical consultation; and Joanne Couchman for assistance with manuscript preparation and figures.
BurgoyneCF, QuigleyHA, ThompsonHW, et al. Early changes in optic disc compliance and surface position in experimental glaucoma. Ophthalmology. 1995;102:1800–1809.
[CrossRef] [PubMed]DerickRJ, PasqualeLR, PeaseME, et al. A clinical study of peripapillary crescents of the optic disc in chronic experimental glaucoma in monkey eyes. Arch Ophthalmol. 1994;112:846–850.
[CrossRef] [PubMed]GaasterlandD, TanishimaT, KuwabaraT. Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci. 1978;17:838–846.
[PubMed]PedersonJE, GaasterlandDE. Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol. 1984;102:1689–1692.
[CrossRef] [PubMed]QuigleyHA, AddicksEM. Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci. 1980;19:126–136.
[PubMed]QuigleyHA, AddicksEM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. 1980;19:137–152.
[PubMed]DandonaL, HendricksonA, QuigleyHA. Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 1991;32:1593–1599.
[PubMed]QuigleyHA, SanchezRM, DunkelbergerGR, et al. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913–920.
[PubMed]HayrehSS, Pe'erJ, ZimmermanMB. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys. J Glaucoma. 1999;8:56–71.
[PubMed]QuigleyHA, HohmanRM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci. 1983;24:1305–1307.
[PubMed]DownsJC, YangH, GirkinC, et al. Three dimensional histomorphometry of the normal and early glaucomatous monkey optic nerve head: neural canal and subarachnoid space architecture. Invest Ophthalmol Vis Sci. 2007;48:3195–3208.
[CrossRef] [PubMed]YangH, DownsJC, GirkinC, et al. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: lamina cribrosa and peripapillary scleral position and thickness. Invest Ophthalmol Vis Sci. 2007;48:4597–4607.
[CrossRef] [PubMed]YangH, DownsJC, BellezzaAJ, et al. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: prelaminar neural tissues and cupping. Invest Ophthalmol Vis Sci. 2007;48:5068–5084.
[CrossRef] [PubMed]BurgoyneCF, DownsJC, BellezzaAJ, et al. Three-dimensional reconstruction of normal and early glaucoma monkey optic nerve head connective tissues. Invest Ophthalmol Vis Sci. 2004;45:4388–4399.
[CrossRef] [PubMed]BellezzaAJ, RintalanCJ, ThompsonHW, et al. Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma. Invest Ophthalmol Vis Sci. 2003;44:623–637.
[CrossRef] [PubMed]SigalIA, FlanaganJG, TertineggI, et al. Finite element modeling of optic nerve head biomechanics. Invest Ophthalmol Vis Sci. 2004;45:4378–4387.
[CrossRef] [PubMed]SigalIA, FlanaganJG, TertineggI, et al. Reconstruction of human optic nerve heads for finite element modeling. Technol Health Care. 2005;13:313–329.
[CrossRef] [PubMed]SigalIA, FlanaganJG, EthierCR. Factors influencing optic nerve head biomechanics. Invest Ophthalmol Vis Sci. 2005;46:4189–4199.
[CrossRef] [PubMed]SigalIA, FlanaganJG, TertineggI, et al. Modeling individual-specific human optic nerve head biomechanics. Part II: influence of material properties. Biomech Model Mechanobiol. .Published online February 27, 2008.
SigalIA, FlanaganJG, TertineggI, et al. Modeling individual-specific human optic nerve head biomechanics. Part I: IOP-induced deformations and influence of geometry. Biomech Model Mechanobiol. .Published online February 29, 2008.
StrouthidisNG, YangH, FortuneB, et al. Detection of the optic nerve head neural canal opening within three-dimensional histomorphometric and spectral domain optical coherence tomography data Sets. Invest Ophthalmol Vis Sci. .Published online August 8, 2008.
BitoLZ, MerrittSQ, DeRousseauCJ. Intraocular pressure of rhesus monkey (Macaca mulatta). I. An initial survey of two free-breeding colonies. Invest Ophthalmol Vis Sci. 1979;18:785–793.
[PubMed]SchottensteinEM. Intraocular pressure and tonometry.RitchR SchieldsMB KrupinT eds.2nd ed. The Glaucomas. 1996;2:407–428.CV Mosby St. Louis.
BlumbergD, CongdonN, JampelH, et al. The effects of sevoflurane and ketamine on intraocular pressure in children during examination under anesthesia. Am J Ophthalmol. 2007;143:494–499.
[CrossRef] [PubMed]AusinschB, RayburnRL, MunsonES, et al. Ketamine and intraocular pressure in children. Anesth Analg. 1976;55:773–775.
[PubMed]PeulerM, GlassDD, ArensJF. Ketamine and intraocular pressure. Anesthesiology. 1975;43:575–578.
[CrossRef] [PubMed]BurkeJA, PotterDE. The ocular effects of xylazine in rabbits, cats, and monkeys. J Ocul Pharmacol. 1986;2:9–21.
[CrossRef] [PubMed]